Wells Fargo
BDSX icon

Wells Fargo’s Biodesix BDSX Stock Holding History

Wells Fargo’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,995
Closed -$513K – 7145
2025
Q1 		$513K Sell
40,995
-826
-2% -$15.9K ﹤0.01% 4082
2024
Q4 		$1.28M Sell
41,821
-4,391
-10% -$129K ﹤0.01% 3530
2024
Q3 		$1.65M Sell
46,212
-347
-0.7% -$11.9K ﹤0.01% 3185
2024
Q2 		$1.42M Buy
46,559
+1,899
+4% +$54.2K ﹤0.01% 3242
2024
Q1 		$1.28M Buy
44,660
+477
+1% +$16.3K ﹤0.01% 3288
2023
Q4 		$1.63M Buy
44,183
+275
+0.6% +$8.63K ﹤0.01% 3071
2023
Q3 		$1.45M Buy
43,908
+1,783
+4% +$49.5K ﹤0.01% 3041
2023
Q2 		$1.04M Buy
42,125
+2,012
+5% +$60.3K ﹤0.01% 3449
2023
Q1 		$1.49M Buy
40,113
+1,421
+4% +$58.3K ﹤0.01% 3098
2022
Q4 		$1.78M Buy
38,692
+251
+0.7% +$6.82K ﹤0.01% 2866
2022
Q3 		$984K Buy
38,441
+11,069
+40% +$427K ﹤0.01% 3254
2022
Q2 		$826K Sell
27,372
-108
-0.4% -$3.51K ﹤0.01% 3415
2022
Q1 		$918K Buy
27,480
+27,098
+7,094% +$1.77M ﹤0.01% 3967
2021
Q4 		$40K Buy
382
+299
+360% +$39K ﹤0.01% 6069
2021
Q3 		$14K Buy
83
+37
+80% +$7.02K ﹤0.01% 6083
2021
Q2 		$12K Sell
46
-46
-50% -$14.5K ﹤0.01% 6075
2021
Q1 		$37K Sell
92
-24
-21% -$10.7K ﹤0.01% 5944
2020
Q4 		$47K Buy
+116
New +$36.1K ﹤0.01% 5599

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Wells Fargo's BDSX Position: Q2 2025 in Review

Wells Fargo sold out of Biodesix (BDSX) in Q2 2025, closing a stake of 40,995 shares — an estimated $513K sold.

Wells Fargo first reported a position in BDSX in Q4 2020 and held it in 18 quarters. The position peaked at $1.78M in Q4 2022. 40 funds tracked by Wall St. Rank hold BDSX as of Q2 2025.

  • Wells Fargo reported no remaining Biodesix position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 40,995 Biodesix shares in Q2 2025, an estimated $513K.
  • Wells Fargo first reported a position in Biodesix in Q4 2020 and held it in 18 quarters.
  • Wells Fargo's Biodesix position peaked at $1.78M in Q4 2022.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.